Let’s work together to transform patient care.
Explore our full suite of solutions.
Our expert-driven, innovative discovery approach—spans research and bioinformatics to clinical product launch via our CLIA-certified lab, and custom production workflows. And it’s all accomplished within a quality-focused, regulatory-aligned environment.
- Tumor-Only. Tumor-Normal and Germline Exomes
- Whole Transcriptome. Targeted RNASeq and ncRNAs
- Functional Binding Multicell Assay
- Exome Analysis Options: SNVs, indels, CNVs, Structural Varients, HLA, Tumor Mutational Burden, Homologous Recombination Deficiency, Annotated VCF
-
RNA Pipeline: Differential Expression, Fusion Detection, Variant Calling, Splice Variants
- Multiomic Signature Discovery, TCR Clonotype Antigen Indentification, Custom Pipeline Building and Predictive Modeling
- Simulate 100s of Drug Combinations against Multiomic Personalized Tumor Models
Coming soon!
Contact us to learn more by clicking here.
